You are here

  • Home
  • Archive
  • Volume 8, Issue 2
  • Management of a patient with mantle cell lymphoma who developed severe neurotoxicity after chimeric antigen receptor T-cell therapy in ZUMA-2

Article metrics

Article menu
XML
Case report
Management of a patient with mantle cell lymphoma who developed severe neurotoxicity after chimeric antigen receptor T-cell therapy in ZUMA-2

 

Online download statistics by month:

Online download statistics by month: October 2020 to November 2024

AbstractFullPdf
Oct 2020505505200
Nov 202023123092
Dec 202011511540
Jan 202111111130
Feb 2021929144
Mar 202111111154
Apr 2021909035
May 2021767636
Jun 202110010061
Jul 2021797971
Aug 2021646482
Sep 2021808061
Oct 2021666647
Nov 2021717146
Dec 2021444416
Jan 2022565816
Feb 2022313422
Mar 2022414339
Apr 2022667232
May 2022738150
Jun 2022676925
Jul 2022727218
Aug 2022737332
Sep 2022484928
Oct 2022525441
Nov 2022313222
Dec 2022323229
Jan 2023303016
Feb 202357587
Mar 2023464720
Apr 2023212113
May 2023282812
Jun 202322227
Jul 2023282819
Aug 2023252516
Sep 202324245
Oct 2023191914
Nov 2023555514
Dec 2023454518
Jan 2024252712
Feb 2024565612
Mar 2024404050
Apr 2024393926
May 2024262816
Jun 2024606013
Jul 2024586029
Aug 2024373412
Sep 2024252520
Oct 2024464615
Nov 2024353720
Total332433561655